Immutep Newsroom

Jefferies Remains a Buy on Immutep Ltd (PRRUF)

TipRanksJul 18 08:23 ET

Analysts' Top Healthcare Picks: UnitedHealth (UNH), Immutep (IMMP)

TipRanksJul 16 21:12 ET

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Immutep (IMMP)

TipRanksJul 15 05:54 ET

Buy Rating Affirmed: Immutep's Efti Shows Promising Results in HNSCC Therapy

TipRanksJul 15 01:37 ET

Buy Rating Affirmed for Immutep Limited Amid Promising Efti Clinical Results in Oncology

TipRanksJul 11 17:30 ET

Immutep Analyst Ratings

BenzingaJun 27 07:10 ET

Analysts Offer Insights on Healthcare Companies: Immutep Ltd (OtherPRRUF) and Redcare Pharmacy (GB:0RJT)

TipRanksMay 22 05:16 ET

Immutep Analyst Ratings

BenzingaMay 17 11:17 ET

Buy Rating on Immutep's Efti: Promising Oncology Treatment With Significant Market Potential

TipRanksMay 17 07:30 ET

Canaccord Starts Immutep at Buy, Price Target Is AU$1.00

MT NewswiresApr 29 21:04 ET

Immutep's Efti Shows Promise in Cancer Therapy, Analyst Maintains Buy Rating

TipRanksApr 26 02:03 ET

Immutep Buy Rating Justified by Strong Clinical Trial Results and Promising Future Prospects

TipRanksApr 25 13:01 ET

Wilsons Sticks to Its Buy Rating for Immutep Ltd (PRRUF)

TipRanksApr 23 01:11 ET

Immutep Ltd (PRRUF) Gets a Buy From Bell Potter

TipRanksApr 4 20:10 ET

Analyst Issues Buy Rating on Immutep Stock Amid Promising Efti Drug Trial Results

TipRanksMar 7 00:05 ET

Buy Rating Affirmed for Immutep on Strong Clinical Pipeline and Market Potential

TipRanksFeb 1 00:35 ET

Jefferies Keeps Their Buy Rating on Immutep Ltd (PRRUF)

TipRanksJan 14 07:16 ET

Immutep Ltd (PRRUF) Gets a Buy From Jefferies

TipRanksJan 7 07:33 ET

Jefferies Reaffirms Their Buy Rating on Immutep Ltd (PRRUF)

TipRanksDec 29, 2023 07:41 ET

Jefferies Sticks to Their Buy Rating for Immutep Ltd (PRRUF)

TipRanksDec 26, 2023 07:38 ET